REVERSAL OF DIRECT FACTOR XA INHIBITORS WITH ANDEXANET ALFA PRIOR TO INVASIVE OR SURGICAL PROCEDURES

被引：0
|
作者：
Bradshaw, Paige [1 ]
Philpott, Carolyn [1 ]
Droege, Christopher [1 ]
Droege, Molly [2 ]
Ernst, Neil [1 ]
Foertsch, Madeline [1 ]
Harger, Nicole [2 ]
Srinivasan, Vasisht [3 ]
Winter, Jessica [1 ]
Keegan, Shaun [1 ]
机构：
[1] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Med Ctr, UC Hlth, Cincinnati, OH 45267 USA
[3] Univ Washington, Sch Med, Seattle, WA 98195 USA
来源：
CRITICAL CARE MEDICINE | 2022年 / 50卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
908
引用
收藏
页码：450 / 450
页数：1
相关论文
共 50 条
  • [21] ANDEXANET ALFA, A UNIVERSAL ANTIDOTE FOR REVERSAL OF ANTICOAGULATION OF FACTOR XA INHIBITORS IN HEALTHY HUMAN VOLUNTEERS
    Crowther, Mark
    Gold, Alex
    Lu, Genmin
    Leeds, Janet
    Wiens, Brian
    Mathur, Vandana
    Castillo, Janice
    Conley, Pamela
    Connolly, Stuart
    Curnutte, John
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (09) : E382 - E382
  • [22] The Efficacy of Andexanet Alfa for the Reversal of Factor Xa Inhibitors Is Not Influenced by Hemodilution with Different Volume Expanders
    Wienhold, Jan
    Rossaint, Rolf
    Vandeput, Eline
    Grottke, Oliver
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (22)
  • [23] Andexanet Alfa Corrects the Interference of Direct Factor Xa Inhibitors on Lupus Anticoagulant Testing
    Baker, Ross I.
    Gilmore, Grace
    McGregor, Scott
    BLOOD, 2016, 128 (22)
  • [24] Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation
    Carpenter, Elise
    Singh, Divita
    Dietrich, Eric
    Gums, John
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2019, 10
  • [25] Comment: Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent
    Gilbert, Brian W.
    Reeder, Jacob A.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (11) : 1167 - 1167
  • [26] Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors
    Fera, Toni
    Burnett, Allison
    Grandoni, Jessica
    Moore, Mary R.
    Nussbaum, Barbara B.
    Pollack Jr, Charles V.
    Rose, Anne E.
    Spinler, Sarah A.
    Streiff, Michael B.
    Turck, Charles J.
    Fanikos, John
    JOURNAL OF PHARMACY PRACTICE, 2025, 38 (01) : 7 - 12
  • [27] Andexanet Alfa, a Universal Antidote for Reversal of Anticoagulation of Factor Xa Inhibitors in Healthy Human Volunteers.
    Crowther, Mark
    Gold, Alexander M.
    Lu Genmin
    Leeds, Janet M.
    Wiens, Brian L.
    Mathur, Vandana
    Castillo, Janice
    Conely, Pamela B.
    Connolly, Stuart J.
    Curnutte, John T.
    STROKE, 2016, 47
  • [28] Administration of Andexanet Alfa for Direct Factor Xa Inhibitor Reversal Precludes Therapeutic Heparinization for Cardiopulmonary Bypass
    Thalji, Nabil K.
    Patel, Prakash A.
    Camire, Rodney M.
    BLOOD, 2019, 134
  • [29] Difficulties Detecting Clinically Relevant Factor Xa Inhibitor Levels Prior to Reversal With Andexanet Alfa for Intracranial Hemorrhage
    Davis, Sarah Elizabeth B.
    Dehne, Kelly A.
    Rubinos, Clio A.
    Lau, Winnie K.
    Northam, Kalynn A.
    NEUROHOSPITALIST, 2022, 12 (02): : 276 - 279
  • [30] Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
    Connolly, Stuart J.
    Milling, Truman J., Jr.
    Eikelboom, John W.
    Gibson, C. Michael
    Curnutte, John T.
    Gold, Alex
    Bronson, Michele D.
    Lu, Genmin
    Conley, Pamela B.
    Verhamme, Peter
    Schmidt, Jeannot
    Middeldorp, Saskia
    Cohen, Alexander T.
    Beyer-Westendorf, Jan
    Albaladejo, Pierre
    Lopez-Sendon, Jose
    Goodman, Shelly
    Leeds, Janet
    Wiens, Brian L.
    Siegal, Deborah M.
    Zotova, Elena
    Meeks, Brandi
    Nakamya, Juliet
    Lim, W. Ting
    Crowther, Mark
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (12): : 1131 - 1141
12345